{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:06:30Z","timestamp":1790154390968,"version":"4.0.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Munich Cluster for Systems Neurology SyNergy","award":["EXC1010"],"award-info":[{"award-number":["EXC1010"]}]},{"name":"ITN Extrabrain","award":["606950"],"award-info":[{"award-number":["606950"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00401-017-1804-9","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T15:29:41Z","timestamp":1515684581000},"page":"695-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["BACE1 inhibition more effectively suppresses initiation than progression of \u03b2-amyloid pathology"],"prefix":"10.1007","volume":"135","author":[{"given":"Finn","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazal","family":"Salihoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Filser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Dorostkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya R.","family":"Shimshek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Brose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"1804_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","unstructured":"Alzheimer\u2019s Association (2016) 2016 Alzheimer\u2019s disease facts and figures. Alzheimers Dement J Alzheimers Assoc 12:459\u2013509","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"1804_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367:795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"1804_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00401-012-1047-8","volume":"124","author":"T Bittner","year":"2012","unstructured":"Bittner T, Burgold S, Dorostkar MM, Fuhrmann M, Wegenast-Braun BM, Schmidt B et al (2012) Amyloid plaque formation precedes dendritic spine loss. Acta Neuropathol (Berl) 124:797\u2013807. https:\/\/doi.org\/10.1007\/s00401-012-1047-8","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR4","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1523\/JNEUROSCI.2288-09.2009","volume":"29","author":"T Bittner","year":"2009","unstructured":"Bittner T, Fuhrmann M, Burgold S, Jung CKE, Volbracht C, Steiner H et al (2009) Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J Neurosci Off J Soc Neurosci 29:10405\u201310409. https:\/\/doi.org\/10.1523\/JNEUROSCI.2288-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-017-0415-y","volume":"5","author":"L Blazquez-Llorca","year":"2017","unstructured":"Blazquez-Llorca L, Valero-Freitag S, Rodrigues EF, Merch\u00e1n-P\u00e9rez \u00c1, Rodr\u00edguez JR, Dorostkar MM et al (2017) High plasticity of axonal pathology in Alzheimer\u2019s disease mouse models. Acta Neuropathol Commun 5:14. https:\/\/doi.org\/10.1186\/s40478-017-0415-y","journal-title":"Acta Neuropathol Commun"},{"key":"1804_CR6","doi-asserted-by":"publisher","first-page":"a006221","DOI":"10.1101\/cshperspect.a006221","volume":"2","author":"K Blennow","year":"2012","unstructured":"Blennow K, Zetterberg H, Fagan AM (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006221. https:\/\/doi.org\/10.1101\/cshperspect.a006221","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1804_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.neurobiolaging.2004.06.010","volume":"26","author":"S Boncristiano","year":"2005","unstructured":"Boncristiano S, Calhoun ME, Howard V, Bondolfi L, Kaeser SA, Wiederhold K-H et al (2005) Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol Aging 26:607\u2013613. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.06.010","journal-title":"Neurobiol Aging"},{"key":"1804_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005072-199005000-00003","volume":"49","author":"H Braak","year":"1990","unstructured":"Braak H, Braak E (1990) Alzheimer\u2019s disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 49:215\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"1804_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239\u2013259","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351\u2013357","journal-title":"Neurobiol Aging"},{"key":"1804_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2003.12.015","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak H, Tredici KD (2004) Alzheimer\u2019s disease: intraneuronal alterations precede insoluble amyloid-\u03b2 formation. Neurobiol Aging 25:713\u2013718. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.12.015","journal-title":"Neurobiol Aging"},{"key":"1804_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-010-0787-6","volume":"121","author":"S Burgold","year":"2010","unstructured":"Burgold S, Bittner T, Dorostkar MM, Kieser D, Fuhrmann M, Mitteregger G et al (2010) In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks. Acta Neuropathol (Berl) 121:327\u2013335. https:\/\/doi.org\/10.1007\/s00401-010-0787-6","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-010-0787-6","volume":"121","author":"S Burgold","year":"2011","unstructured":"Burgold S, Bittner T, Dorostkar MM, Kieser D, Fuhrmann M, Mitteregger G et al (2011) In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks. Acta Neuropathol (Berl) 121:327\u2013335. https:\/\/doi.org\/10.1007\/s00401-010-0787-6","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-30","volume":"2","author":"S Burgold","year":"2014","unstructured":"Burgold S, Filser S, Dorostkar MM, Schmidt B, Herms J (2014) In vivo imaging reveals sigmoidal growth kinetic of \u03b2-amyloid plaques. Acta Neuropathol Commun 2:1","journal-title":"Acta Neuropathol Commun"},{"key":"1804_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1096\/fj.10-167213","volume":"25","author":"W-P Chang","year":"2011","unstructured":"Chang W-P, Huang X, Downs D, Cirrito JR, Koelsch G, Holtzman DM et al (2011) Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice. FASEB J Off Publ Fed Am Soc Exp Biol 25:775\u2013784. https:\/\/doi.org\/10.1096\/fj.10-167213","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"1804_CR16","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1038\/emboj.2013.146","volume":"32","author":"C Cheret","year":"2013","unstructured":"Cheret C, Willem M, Fricker FR, Wende H, Wulf-Goldenberg A, Tahirovic S et al (2013) Bace1 and neuregulin-1 cooperate to control formation and maintenance of muscle spindles. EMBO J 32:2015\u20132028. https:\/\/doi.org\/10.1038\/emboj.2013.146","journal-title":"EMBO J"},{"key":"1804_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","volume":"38","author":"B Strooper De","year":"2003","unstructured":"De Strooper B (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-Secretase complex. Neuron 38:9\u201312","journal-title":"Neuron"},{"key":"1804_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cell.2014.10.016","volume":"159","author":"B Strooper De","year":"2014","unstructured":"De Strooper B (2014) Lessons from a failed \u03b3-secretase Alzheimer trial. Cell 159:721\u2013726. https:\/\/doi.org\/10.1016\/j.cell.2014.10.016","journal-title":"Cell"},{"key":"1804_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/19083","volume":"398","author":"B Strooper De","year":"1999","unstructured":"De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS et al (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518\u2013522. https:\/\/doi.org\/10.1038\/19083","journal-title":"Nature"},{"key":"1804_CR20","doi-asserted-by":"publisher","first-page":"30236","DOI":"10.1074\/jbc.M113.480079","volume":"288","author":"M Deng","year":"2013","unstructured":"Deng M, He W, Tan Y, Han H, Hu X, Xia K et al (2013) Increased expression of reticulon 3 in neurons leads to reduced axonal transport of \u03b2 site amyloid precursor protein-cleaving enzyme 1. J Biol Chem 288:30236\u201330245. https:\/\/doi.org\/10.1074\/jbc.M113.480079","journal-title":"J Biol Chem"},{"key":"1804_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuroscience.2015.08.037","volume":"307","author":"L Devi","year":"2015","unstructured":"Devi L, Ohno M (2015) Effects of BACE1 haploinsufficiency on APP processing and A\u03b2 concentrations in male and female 5XFAD Alzheimer mice at different disease stages. Neuroscience 307:128\u2013137. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.08.037","journal-title":"Neuroscience"},{"key":"1804_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1567205012666141218125042","volume":"12","author":"L Devi","year":"2015","unstructured":"Devi L, Tang J, Ohno M (2015) Beneficial effects of the \u03b2-secretase inhibitor GRL-8234 in 5XFAD Alzheimer\u2019s transgenic mice lessen during disease progression. Curr Alzheimer Res 12:13\u201321","journal-title":"Curr Alzheimer Res"},{"key":"1804_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphys.2012.00008","volume":"3","author":"B Dislich","year":"2012","unstructured":"Dislich B, Lichtenthaler SF (2012) The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer\u2019s disease and beyond. Front Physiol 3:8. https:\/\/doi.org\/10.3389\/fphys.2012.00008","journal-title":"Front Physiol"},{"key":"1804_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cne.21176","volume":"500","author":"H Dong","year":"2007","unstructured":"Dong H, Martin MV, Chambers S, Csernansky JG (2007) Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J Comp Neurol 500:311\u2013321. https:\/\/doi.org\/10.1002\/cne.21176","journal-title":"J Comp Neurol"},{"key":"1804_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier M-C (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol (Berl) 118:5\u201336. https:\/\/doi.org\/10.1007\/s00401-009-0532-1","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopsych.2014.10.013","volume":"77","author":"S Filser","year":"2015","unstructured":"Filser S, Ovsepian SV, Masana M, Blazquez-Llorca L, Brandt Elvang A, Volbracht C et al (2015) Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions. Biol Psychiatry 77:729\u2013739. https:\/\/doi.org\/10.1016\/j.biopsych.2014.10.013","journal-title":"Biol Psychiatry"},{"key":"1804_CR27","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1523\/JNEUROSCI.5062-06.2007","volume":"27","author":"M Fuhrmann","year":"2007","unstructured":"Fuhrmann M, Mitteregger G, Kretzschmar H, Herms J (2007) Dendritic pathology in prion disease starts at the synaptic spine. J Neurosci Off J Soc Neurosci 27:6224\u20136233. https:\/\/doi.org\/10.1523\/JNEUROSCI.5062-06.2007","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","volume":"59","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59:1381\u20131389","journal-title":"Arch Neurol"},{"key":"1804_CR29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","volume":"164","author":"H Fukumoto","year":"2004","unstructured":"Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164:719\u2013725","journal-title":"Am J Pathol"},{"key":"1804_CR30","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.1523\/JNEUROSCI.2884-10.2010","volume":"30","author":"H Fukumoto","year":"2010","unstructured":"Fukumoto H, Takahashi H, Tarui N, Matsui J, Tomita T, Hirode M et al (2010) A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 30:11157\u201311166. https:\/\/doi.org\/10.1523\/JNEUROSCI.2884-10.2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"1804_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1379.003","volume":"1097","author":"J Grutzendler","year":"2007","unstructured":"Grutzendler J, Helmin K, Tsai J, Gan W-B (2007) Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer\u2019s disease. Ann NY Acad Sci 1097:30\u201339. https:\/\/doi.org\/10.1196\/annals.1379.003","journal-title":"Ann NY Acad Sci"},{"key":"1804_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","volume":"23","author":"C Haass","year":"2004","unstructured":"Haass C (2004) Take five\u2014BACE and the gamma-secretase quartet conduct Alzheimer\u2019s amyloid beta-peptide generation. EMBO J 23:483\u2013488. https:\/\/doi.org\/10.1038\/sj.emboj.7600061","journal-title":"EMBO J"},{"key":"1804_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"1804_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"key":"1804_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","volume":"66","author":"JD Harper","year":"1997","unstructured":"Harper JD, Lansbury PT (1997) Models of amyloid seeding in Alzheimer\u2019s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66:385\u2013407. https:\/\/doi.org\/10.1146\/annurev.biochem.66.1.385","journal-title":"Annu Rev Biochem"},{"key":"1804_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1523\/JNEUROSCI.5147-10.2011","volume":"31","author":"JK Hefendehl","year":"2011","unstructured":"Hefendehl JK, Wegenast-Braun BM, Liebig C, Eicke D, Milford D, Calhoun ME et al (2011) Long-term in vivo imaging of \u03b2-amyloid plaque appearance and growth in a mouse model of cerebral \u03b2-amyloidosis. J Neurosci 31:624\u2013629. https:\/\/doi.org\/10.1523\/JNEUROSCI.5147-10.2011","journal-title":"J Neurosci"},{"key":"1804_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/cn900015v","volume":"1","author":"E Hellstrand","year":"2010","unstructured":"Hellstrand E, Boland B, Walsh DM, Linse S (2010) Amyloid \u03b2-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci 1:13\u201318. https:\/\/doi.org\/10.1021\/cn900015v","journal-title":"ACS Chem Neurosci"},{"key":"1804_CR39","doi-asserted-by":"publisher","first-page":"15544","DOI":"10.1523\/JNEUROSCI.2073-11.2011","volume":"31","author":"E Herzog","year":"2011","unstructured":"Herzog E, Nadrigny F, Silm K, Biesemann C, Helling I, Bersot T et al (2011) In vivo imaging of intersynaptic vesicle exchange using VGLUT1Venus knock-in mice. J Neurosci 31:15544\u201315559. https:\/\/doi.org\/10.1523\/JNEUROSCI.2073-11.2011","journal-title":"J Neurosci"},{"key":"1804_CR40","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nprot.2009.89","volume":"4","author":"A Holtmaat","year":"2009","unstructured":"Holtmaat A, Bonhoeffer T, Chow DK, Chuckowree J, De Paola V, Hofer SB et al (2009) Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat Protoc 4:1128\u20131144. https:\/\/doi.org\/10.1038\/nprot.2009.89","journal-title":"Nat Protoc"},{"key":"1804_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102","journal-title":"Science"},{"key":"1804_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/mcne.1999.0811","volume":"14","author":"I Hussain","year":"1999","unstructured":"Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C et al (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14:419\u2013427. https:\/\/doi.org\/10.1006\/mcne.1999.0811","journal-title":"Mol Cell Neurosci"},{"key":"1804_CR43","doi-asserted-by":"publisher","first-page":"11621","DOI":"10.1523\/JNEUROSCI.1405-14.2014","volume":"34","author":"H Jacobsen","year":"2014","unstructured":"Jacobsen H, Ozmen L, Caruso A, Narquizian R, Hilpert H, Jacobsen B et al (2014) Combined treatment with a BACE inhibitor and anti-A\u03b2 antibody gantenerumab enhances amyloid reduction in APPLondon mice. J Neurosci 34:11621\u201311630. https:\/\/doi.org\/10.1523\/JNEUROSCI.1405-14.2014","journal-title":"J Neurosci"},{"key":"1804_CR44","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1371\/journal.pmed.0020355","volume":"2","author":"JL Jankowsky","year":"2005","unstructured":"Jankowsky JL, Slunt HH, Gonzales V, Savonenko AV, Wen JC, Jenkins NA et al (2005) Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med 2:e355. https:\/\/doi.org\/10.1371\/journal.pmed.0020355","journal-title":"PLoS Med"},{"key":"1804_CR45","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","volume":"73","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Lansbury PT (1993) Seeding \u201cone-dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer\u2019s disease and scrapie? Cell 73:1055\u20131058","journal-title":"Cell"},{"key":"1804_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S et al (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399. https:\/\/doi.org\/10.1038\/nature11283","journal-title":"Nature"},{"key":"1804_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","volume":"126","author":"PC Kandalepas","year":"2013","unstructured":"Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R (2013) The Alzheimer\u2019s \u03b2-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol (Berl) 126:329\u2013352. https:\/\/doi.org\/10.1007\/s00401-013-1152-3","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR48","doi-asserted-by":"crossref","unstructured":"Kennedy ME, Stamford AW, Chen X, Cox K, Cumming JN, Dockendorf MF et al (2016) The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients. Sci Transl Med. 8:363ra150. https:\/\/doi.org\/10.1126\/scitranslmed.aad9704","DOI":"10.1126\/scitranslmed.aad9704"},{"key":"1804_CR49","doi-asserted-by":"publisher","first-page":"8631","DOI":"10.1073\/pnas.1708106114","volume":"114","author":"AD Keskin","year":"2017","unstructured":"Keskin AD, Keku\u0161 M, Adelsberger H, Neumann U, Shimshek DR, Song B et al (2017) BACE inhibition-dependent repair of Alzheimer\u2019s pathophysiology. Proc Natl Acad Sci 114:8631\u20138636. https:\/\/doi.org\/10.1073\/pnas.1708106114","journal-title":"Proc Natl Acad Sci"},{"key":"1804_CR50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(01)03294-2","volume":"926","author":"DL King","year":"2002","unstructured":"King DL, Arendash GW (2002) Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res 926:58\u201368","journal-title":"Brain Res"},{"key":"1804_CR51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/glycob\/cwp003","volume":"19","author":"S Kitazume","year":"2009","unstructured":"Kitazume S, Oka R, Ogawa K, Futakawa S, Hagiwara Y, Takikawa H et al (2009) Molecular insights into beta-galactoside alpha2,6-sialyltransferase secretion in vivo. Glycobiology 19:479\u2013487. https:\/\/doi.org\/10.1093\/glycob\/cwp003","journal-title":"Glycobiology"},{"key":"1804_CR52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","volume":"61","author":"WE Klunk","year":"2002","unstructured":"Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP et al (2002) Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol 61:797\u2013805","journal-title":"J Neuropathol Exp Neurol"},{"key":"1804_CR53","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cercor\/bhn111","volume":"19","author":"S Knafo","year":"2009","unstructured":"Knafo S, Alonso-Nanclares L, Gonzalez-Soriano J, Merino-Serrais P, Fernaud-Espinosa I, Ferrer I et al (2009) Widespread changes in dendritic spines in a model of Alzheimer\u2019s disease. Cereb Cortex NY 1991 19:586\u2013592. https:\/\/doi.org\/10.1093\/cercor\/bhn111","journal-title":"Cereb Cortex NY 1991"},{"key":"1804_CR54","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1038\/emboj.2012.173","volume":"31","author":"P-H Kuhn","year":"2012","unstructured":"Kuhn P-H, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M et al (2012) Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J 31:3157\u20133168. https:\/\/doi.org\/10.1038\/emboj.2012.173","journal-title":"EMBO J"},{"key":"1804_CR55","doi-asserted-by":"publisher","first-page":"S411","DOI":"10.1016\/j.jalz.2013.11.004","volume":"10","author":"DK Lahiri","year":"2014","unstructured":"Lahiri DK, Maloney B, Long JM, Greig NH (2014) Lessons from a BACE1 inhibitor trial: off-site but not off base. Alzheimers Dement J Alzheimers Assoc 10:S411\u2013S419. https:\/\/doi.org\/10.1016\/j.jalz.2013.11.004","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"1804_CR56","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1073\/pnas.0205689101","volume":"101","author":"R Li","year":"2004","unstructured":"Li R, Lindholm K, Yang L-B, Yue X, Citron M, Yan R et al (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer\u2019s disease patients. Proc Natl Acad Sci USA 101:3632\u20133637. https:\/\/doi.org\/10.1073\/pnas.0205689101","journal-title":"Proc Natl Acad Sci USA"},{"key":"1804_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/85059","volume":"4","author":"Y Luo","year":"2001","unstructured":"Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P et al (2001) Mice deficient in BACE1, the Alzheimer\u2019s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4:231\u2013232. https:\/\/doi.org\/10.1038\/85059","journal-title":"Nat Neurosci"},{"key":"1804_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","volume":"1161","author":"T Matsui","year":"2007","unstructured":"Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP et al (2007) Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease. Brain Res 1161:116\u2013123. https:\/\/doi.org\/10.1016\/j.brainres.2007.05.050","journal-title":"Brain Res"},{"key":"1804_CR59","doi-asserted-by":"publisher","first-page":"16507","DOI":"10.1523\/JNEUROSCI.3647-11.2011","volume":"31","author":"PC May","year":"2011","unstructured":"May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN et al (2011) Robust central reduction of amyloid-\u03b2 in humans with an orally available, non-peptidic \u03b2-secretase inhibitor. J Neurosci Off J Soc Neurosci 31:16507\u201316516. https:\/\/doi.org\/10.1523\/JNEUROSCI.3647-11.2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1523\/JNEUROSCI.4129-14.2015","volume":"35","author":"PC May","year":"2015","unstructured":"May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ et al (2015) The potent BACE1 inhibitor LY2886721 elicits robust central A\u03b2 pharmacodynamic responses in mice, dogs, and humans. J Neurosci Off J Soc Neurosci 35:1199\u20131210. https:\/\/doi.org\/10.1523\/JNEUROSCI.4129-14.2015","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00401-013-1137-2","volume":"126","author":"JF McCarter","year":"2013","unstructured":"McCarter JF, Liebscher S, Bachhuber T, Abou-Ajram C, H\u00fcbener M, Hyman BT et al (2013) Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol (Berl) 126:179\u2013188. https:\/\/doi.org\/10.1007\/s00401-013-1137-2","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR62","doi-asserted-by":"publisher","first-page":"26326","DOI":"10.1074\/jbc.M611687200","volume":"282","author":"L McConlogue","year":"2007","unstructured":"McConlogue L, Buttini M, Anderson JP, Brigham EF, Chen KS, Freedman SB et al (2007) Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice. J Biol Chem 282:26326\u201326334. https:\/\/doi.org\/10.1074\/jbc.M611687200","journal-title":"J Biol Chem"},{"key":"1804_CR63","doi-asserted-by":"publisher","unstructured":"Neumann U, Rueeger H, Machauer R, Veenstra SJ, Lueoend RM, Tintelnot-Blomley M, et al. (2015) A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-\u03b2 and neuroinflammation in APP transgenic mice. Mol Neurodegener 10. https:\/\/doi.org\/10.1186\/s13024-015-0033-8","DOI":"10.1186\/s13024-015-0033-8"},{"key":"1804_CR64","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L et al (2006) A\u03b242-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7:940\u2013946. https:\/\/doi.org\/10.1038\/sj.embor.7400784","journal-title":"EMBO Rep"},{"key":"1804_CR65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2174\/15672050113109990152","volume":"10","author":"KR Sadleir","year":"2013","unstructured":"Sadleir KR, Bennett DA, Schneider JA, Vassar R (2013) Elevated A\u03b242 in aged, non-demented individuals with cerebral atherosclerosis. Curr Alzheimer Res 10:785\u2013789","journal-title":"Curr Alzheimer Res"},{"key":"1804_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-10-1","volume":"10","author":"KR Sadleir","year":"2015","unstructured":"Sadleir KR, Eimer WA, Cole SL, Vassar R (2015) A\u03b2 reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Mol Neurodegener 10:1. https:\/\/doi.org\/10.1186\/1750-1326-10-1","journal-title":"Mol Neurodegener"},{"key":"1804_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","volume":"132","author":"KR Sadleir","year":"2016","unstructured":"Sadleir KR, Kandalepas PC, Buggia-Pr\u00e9vot V, Nicholson DA, Thinakaran G, Vassar R (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease. Acta Neuropathol (Berl) 132:235\u2013256. https:\/\/doi.org\/10.1007\/s00401-016-1558-9","journal-title":"Acta Neuropathol (Berl)"},{"key":"1804_CR68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","volume":"89","author":"J Shen","year":"1997","unstructured":"Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89:629\u2013639","journal-title":"Cell"},{"key":"1804_CR69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","volume":"258","author":"M Shoji","year":"1992","unstructured":"Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM et al (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258:126\u2013129","journal-title":"Science"},{"key":"1804_CR70","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"S Sinha","year":"1999","unstructured":"Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D et al (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402:537\u2013540. https:\/\/doi.org\/10.1038\/990114","journal-title":"Nature"},{"key":"1804_CR71","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez-Calvet M, Araque Caballero M\u00c1, Kleinberger G, Bateman RJ, Fagan AM, Morris JC et al (2016) Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury. Sci Transl Med 8:369ra178. https:\/\/doi.org\/10.1126\/scitranslmed.aag1767","DOI":"10.1126\/scitranslmed.aag1767"},{"key":"1804_CR72","unstructured":"Sullivan M (2017) Unblinded data show extent of verubecestat\u2019s failure in mild-moderate Alzheimer\u2019s. EPOCH, Conference Coverage, Clinical Neurology News"},{"key":"1804_CR73","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1523\/JNEUROSCI.2262-14.2015","volume":"35","author":"DR Thakker","year":"2015","unstructured":"Thakker DR, Sankaranarayanan S, Weatherspoon MR, Harrison J, Pierdomenico M, Heisel JM et al (2015) Centrally delivered BACE1 inhibitor activates microglia, and reverses amyloid pathology and cognitive deficit in aged Tg2576 mice. J Neurosci 35:6931\u20136936. https:\/\/doi.org\/10.1523\/JNEUROSCI.2262-14.2015","journal-title":"J Neurosci"},{"key":"1804_CR74","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"1804_CR75","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nn1335","volume":"7","author":"J Tsai","year":"2004","unstructured":"Tsai J, Grutzendler J, Duff K, Gan W-B (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7:1181\u20131183. https:\/\/doi.org\/10.1038\/nn1335","journal-title":"Nat Neurosci"},{"key":"1804_CR76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P et al (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735\u2013741","journal-title":"Science"},{"key":"1804_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-1-4","volume":"1","author":"KS Vetrivel","year":"2006","unstructured":"Vetrivel KS, Zhang Y, Xu H, Thinakaran G (2006) Pathological and physiological functions of presenilins. Mol Neurodegener 1:4. https:\/\/doi.org\/10.1186\/1750-1326-1-4","journal-title":"Mol Neurodegener"},{"key":"1804_CR78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O et al (2013) Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12:357\u2013367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9","journal-title":"Lancet Neurol"},{"key":"1804_CR79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/156720508783954767","volume":"5","author":"MS Wolfe","year":"2008","unstructured":"Wolfe MS (2008) Gamma-secretase inhibition and modulation for Alzheimer\u2019s disease. Curr Alzheimer Res 5:158\u2013164","journal-title":"Curr Alzheimer Res"},{"key":"1804_CR80","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1126\/science.1096187","volume":"305","author":"MS Wolfe","year":"2004","unstructured":"Wolfe MS, Kopan R (2004) Intramembrane proteolysis: theme and variations. Science 305:1119\u20131123. https:\/\/doi.org\/10.1126\/science.1096187","journal-title":"Science"},{"key":"1804_CR81","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/387288a0","volume":"387","author":"PC Wong","year":"1997","unstructured":"Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME et al (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387:288\u2013292. https:\/\/doi.org\/10.1038\/387288a0","journal-title":"Nature"},{"key":"1804_CR82","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1074\/jbc.M109.066753","volume":"285","author":"H Yamakawa","year":"2010","unstructured":"Yamakawa H, Yagishita S, Futai E, Ishiura S (2010) beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the \u201cSwedish mutant\u201d amyloid precursor protein. J Biol Chem 285:1634\u20131642. https:\/\/doi.org\/10.1074\/jbc.M109.066753","journal-title":"J Biol Chem"},{"key":"1804_CR83","doi-asserted-by":"publisher","first-page":"10706","DOI":"10.1523\/JNEUROSCI.2637-09.2009","volume":"29","author":"P Yan","year":"2009","unstructured":"Yan P, Bero AW, Cirrito JR, Xiao Q, Hu X, Wang Y et al (2009) Characterizing the appearance and growth of amyloid plaques in APP\/PS1 mice. J Neurosci Off J Soc Neurosci 29:10706\u201310714. https:\/\/doi.org\/10.1523\/JNEUROSCI.2637-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR84","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"R Yan","year":"1999","unstructured":"Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM et al (1999) Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity. Nature 402:533\u2013537. https:\/\/doi.org\/10.1038\/990107","journal-title":"Nature"},{"key":"1804_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"L-B Yang","year":"2003","unstructured":"Yang L-B, Lindholm K, Yan R, Citron M, Xia W, Yang X-L et al (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9:3\u20134. https:\/\/doi.org\/10.1038\/nm0103-3","journal-title":"Nat Med"},{"key":"1804_CR86","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1111\/j.1460-9568.2009.07017.x","volume":"30","author":"X-M Zhang","year":"2009","unstructured":"Zhang X-M, Cai Y, Xiong K, Cai H, Luo X-G, Feng J-C et al (2009) Beta-secretase-1 elevation in transgenic mouse models of Alzheimer\u2019s disease is associated with synaptic\/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 30:2271\u20132283. https:\/\/doi.org\/10.1111\/j.1460-9568.2009.07017.x","journal-title":"Eur J Neurosci"},{"key":"1804_CR87","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","volume":"27","author":"J Zhao","year":"2007","unstructured":"Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O\u2019Connor T et al (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer\u2019s disease pathogenesis. J Neurosci Off J Soc Neurosci 27:3639\u20133649. https:\/\/doi.org\/10.1523\/JNEUROSCI.4396-06.2007","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1804_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.12.023","author":"K Zhu","year":"2016","unstructured":"Zhu K, Xiang X, Filser S, Marinkovi\u0107 P, Dorostkar MM, Crux S et al (2016) Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6. Biol Psychiatry. https:\/\/doi.org\/10.1016\/j.biopsych.2016.12.023","journal-title":"Biol Psychiatry"},{"key":"1804_CR89","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jalz.2008.05.2479","volume":"4","author":"K Ziegler-Graham","year":"2008","unstructured":"Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM (2008) Worldwide variation in the doubling time of Alzheimer\u2019s disease incidence rates. Alzheimers Dement J Alzheimers Assoc 4:316\u2013323. https:\/\/doi.org\/10.1016\/j.jalz.2008.05.2479","journal-title":"Alzheimers Dement J Alzheimers Assoc"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1804-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1804-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1804-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T11:55:54Z","timestamp":1523966154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1804-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1804"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1804-9","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}